Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA
Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA
Search for other papers by Elena V Varlamov in
Google Scholar
PubMed
Search for other papers by Dan Alexandru Niculescu in
Google Scholar
PubMed
Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA
Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA
Search for other papers by Swechya Banskota in
Google Scholar
PubMed
Search for other papers by Simona Andreea Galoiu in
Google Scholar
PubMed
Search for other papers by Catalina Poiana in
Google Scholar
PubMed
Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA
Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA
Search for other papers by Maria Fleseriu in
Google Scholar
PubMed
Introduction Acromegaly is a rare disease that is caused by excessive growth hormone (GH) secretion by a pituitary adenoma ( 1 , 2 , 3 ). The clinical picture of active acromegaly is characterized by a combination of symptoms, signs, and
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Henrik Falhammar in
Google Scholar
PubMed
Department of Breast and Endocrine Surgery, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Magnus Kjellman in
Google Scholar
PubMed
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Jan Calissendorff in
Google Scholar
PubMed
is a serious condition which can be fatal if not diagnosed and/or managed appropriately ( 1 , 5 ). It has been estimated that at least 25% of all affected by pheochromocytomas were never diagnosed during life ( 6 ). The presenting symptoms of
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Sanaa Mrabeti in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
, respectively) ( 8 ). For most patients, administration of levothyroxine is sufficient to resolve symptoms of hypothyroidism and maintain quality of life ( 1 , 2 , 3 ). However, a minority of people with hypothyroidism continue to report symptoms reminiscent
Search for other papers by Yen Kheng Tan in
Google Scholar
PubMed
Search for other papers by Yu Heng Kwan in
Google Scholar
PubMed
Search for other papers by David Choon Liang Teo in
Google Scholar
PubMed
Search for other papers by Marieke Velema in
Google Scholar
PubMed
Search for other papers by Jaap Deinum in
Google Scholar
PubMed
Search for other papers by Pei Ting Tan in
Google Scholar
PubMed
Search for other papers by Meifen Zhang in
Google Scholar
PubMed
Search for other papers by Joan Joo Ching Khoo in
Google Scholar
PubMed
Search for other papers by Wann Jia Loh in
Google Scholar
PubMed
Search for other papers by Linsey Gani in
Google Scholar
PubMed
Search for other papers by Thomas F J King in
Google Scholar
PubMed
Search for other papers by Eberta Jun Hui Tan in
Google Scholar
PubMed
Search for other papers by Shui Boon Soh in
Google Scholar
PubMed
Search for other papers by Vanessa Shu Chuan Au in
Google Scholar
PubMed
Search for other papers by Tunn Lin Tay in
Google Scholar
PubMed
Search for other papers by Lily Mae Quevedo Dacay in
Google Scholar
PubMed
Search for other papers by Keng Sin Ng in
Google Scholar
PubMed
Search for other papers by Kang Min Wong in
Google Scholar
PubMed
Search for other papers by Andrew Siang Yih Wong in
Google Scholar
PubMed
Search for other papers by Foo Cheong Ng in
Google Scholar
PubMed
Search for other papers by Tar Choon Aw in
Google Scholar
PubMed
Search for other papers by Yvonne Hui Bin Chan in
Google Scholar
PubMed
Search for other papers by Khim Leng Tong in
Google Scholar
PubMed
Search for other papers by Sheldon Shao Guang Lee in
Google Scholar
PubMed
Search for other papers by Siang Chew Chai in
Google Scholar
PubMed
Search for other papers by Troy Hai Kiat Puar in
Google Scholar
PubMed
psychological symptoms, which may improve after treatment ( 5 ). Hence, in this prospective observational study, we aimed to assess for both HRQoL and depressive symptoms in a cohort of patients with PA after appropriate treatment with either surgical or
Search for other papers by Jens P Goetze in
Google Scholar
PubMed
Search for other papers by Linda M Hilsted in
Google Scholar
PubMed
Search for other papers by Jens F Rehfeld in
Google Scholar
PubMed
Search for other papers by Urban Alehagen in
Google Scholar
PubMed
hampered the general use of CgA as a biomarker, because CgA processing is extensive, variable, and harbors a plethora of fragments. In the present study, we examined a cohort of elderly patients with symptoms suggestive of heart failure, i.e. tiredness
Search for other papers by Greta B Raglan in
Google Scholar
PubMed
Search for other papers by Louis A Schmidt in
Google Scholar
PubMed
Department of Neuroscience, Georgetown University, Washington, District of Columbia, USA
Search for other papers by Jay Schulkin in
Google Scholar
PubMed
generalized anxiety and depressive disorders, posttraumatic stress disorder (PTSD) and social anxiety. Each of these areas of research has implicated glucocorticoid levels, either high or low, in the presentation of variable symptoms of anxiety ( 3 ). Despite
Search for other papers by Małgorzata Kałużna in
Google Scholar
PubMed
Search for other papers by Pola Kompf in
Google Scholar
PubMed
Search for other papers by Katarzyna Wachowiak-Ochmańska in
Google Scholar
PubMed
Search for other papers by Jerzy Moczko in
Google Scholar
PubMed
Search for other papers by Aleksandra Królczyk in
Google Scholar
PubMed
Search for other papers by Adam Janicki in
Google Scholar
PubMed
Search for other papers by Karol Szapel in
Google Scholar
PubMed
Search for other papers by Marian Grzymisławski in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
Search for other papers by Katarzyna Ziemnicka in
Google Scholar
PubMed
, associated with a change in the form of stool and/or its frequency, with such symptoms starting 6 months before diagnosis and being present for the previous 3 months ( 11 ). Clinical diagnosis necessitates the exclusion of underlying organic disease, history
Search for other papers by Natalie Rogowski-Lehmann in
Google Scholar
PubMed
Search for other papers by Aikaterini Geroula in
Google Scholar
PubMed
Search for other papers by Aleksander Prejbisz in
Google Scholar
PubMed
Search for other papers by Henri J L M Timmers in
Google Scholar
PubMed
Search for other papers by Felix Megerle in
Google Scholar
PubMed
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Stephanie M J Fliedner in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
Search for other papers by Anthony Stell in
Google Scholar
PubMed
Search for other papers by Andrzej Januszewicz in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Jacques W M Lenders in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
analyses indicate that life-threating events with cardiovascular complications including hypertensive crisis and catecholamine-induced cardiomyopathy are not uncommon even as first presentation of disease ( 3 , 4 ). The symptoms that occur in patients with
Search for other papers by Michelle Hadjiconstantinou in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
Search for other papers by Hamidreza Mani in
Google Scholar
PubMed
Search for other papers by Naina Patel in
Google Scholar
PubMed
Search for other papers by Miles Levy in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
Search for other papers by Melanie Davies in
Google Scholar
PubMed
Search for other papers by Kamlesh Khunti in
Google Scholar
PubMed
Search for other papers by Margaret Stone in
Google Scholar
PubMed
‘freak’ ( 12 ). Lack of information given to women diagnosed with PCOS may also create confusion about why they are experiencing symptoms, leading to feelings of guilt and lack of control ( 4 , 12 , 13 ). It is clear that a diagnosis of PCOS has
Search for other papers by Navid Tabriz in
Google Scholar
PubMed
Search for other papers by Kilian Gloy in
Google Scholar
PubMed
Search for other papers by Astrid Schantzen in
Google Scholar
PubMed
Search for other papers by Dennis Fried in
Google Scholar
PubMed
Search for other papers by Dirk Weyhe in
Google Scholar
PubMed
Search for other papers by Verena Uslar in
Google Scholar
PubMed
patient sample was performed, for the results see Table 1 . Of these 98 patients, 91 participated in and completed the retest questionnaire. Out of these 91 patients, only those with self-reported stable disease symptoms and no change in medication were